Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Aghemo

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Viral Hepatitis|January 12, 2012
Clinical drivers in naïve patient eligibility for treatment of chronic hepatitis CE Degasperi, A Aghemo
Medical Hypotheses|July 25, 2012
Eukaryotic initiation factor 5B: a new player for the anti-hepatitis C virus effect of ribavirin?E Galmozzi, A Aghemo, M Colombo
Journal of Viral Hepatitis|January 12, 2012
Comparative trials of peginterferon α2a and peginterferon α2b for chronic hepatitis CM Rumi, A Aghemo, G M Prati
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 15, 2014
High-resolution melting assay for genotyping of IFNL4-associated dinucleotide variant rs368234815E Galmozzi, F Facchetti, R Perbellini, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989
Osmoregulation of vasopressin during acute lowering of arterial pressure by clonidine in moderate hypertensionA Del Bo, M Marabini, A Aghemo, et al.
Journal of Virological Methods|December 4, 2012
Allelic inhibition of displacement activity: a simplified one tube allele-specific PCR for evaluation of ITPA polymorphismsE Galmozzi, F Facchetti, E Degasperi, et al.
European Journal of Internal Medicine|June 14, 2008
Recovery after L-DOPA treatment in peginterferon and ribavirin induced parkinsonismA Bersano, A Aghemo, M G Rumi, et al.
European Review for Medical and Pharmacological Sciences|January 14, 2017
Treatment of patients with chronic hepatitis C infection in Lombardia: a report by the Lombardia Hepatitis NetworkA Aghemo, R Bruno, M Colombo, et al.
Journal of Thrombosis and Haemostasis : JTH|October 6, 2009
Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapyM E Mancuso, M G Rumi, A Aghemo, et al.
Journal of Viral Hepatitis|April 23, 2014
Ribavirin suppresses erythroid differentiation and proliferation in chronic hepatitis C patientsL Ronzoni, A Aghemo, M G Rumi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Viral Hepatitis|January 12, 2012
Clinical drivers in naïve patient eligibility for treatment of chronic hepatitis CE Degasperi, A Aghemo
Medical Hypotheses|July 25, 2012
Eukaryotic initiation factor 5B: a new player for the anti-hepatitis C virus effect of ribavirin?E Galmozzi, A Aghemo, M Colombo
Journal of Viral Hepatitis|January 12, 2012
Comparative trials of peginterferon α2a and peginterferon α2b for chronic hepatitis CM Rumi, A Aghemo, G M Prati
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 15, 2014
High-resolution melting assay for genotyping of IFNL4-associated dinucleotide variant rs368234815E Galmozzi, F Facchetti, R Perbellini, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989
Osmoregulation of vasopressin during acute lowering of arterial pressure by clonidine in moderate hypertensionA Del Bo, M Marabini, A Aghemo, et al.
Journal of Virological Methods|December 4, 2012
Allelic inhibition of displacement activity: a simplified one tube allele-specific PCR for evaluation of ITPA polymorphismsE Galmozzi, F Facchetti, E Degasperi, et al.
European Journal of Internal Medicine|June 14, 2008
Recovery after L-DOPA treatment in peginterferon and ribavirin induced parkinsonismA Bersano, A Aghemo, M G Rumi, et al.
European Review for Medical and Pharmacological Sciences|January 14, 2017
Treatment of patients with chronic hepatitis C infection in Lombardia: a report by the Lombardia Hepatitis NetworkA Aghemo, R Bruno, M Colombo, et al.
Journal of Thrombosis and Haemostasis : JTH|October 6, 2009
Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapyM E Mancuso, M G Rumi, A Aghemo, et al.
Journal of Viral Hepatitis|April 23, 2014
Ribavirin suppresses erythroid differentiation and proliferation in chronic hepatitis C patientsL Ronzoni, A Aghemo, M G Rumi, et al.
Pageof 2